Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/26/2026

1. INTU
2. DKS
3. NVDA
4. META
5. ZM
6. SMTC
7. SPY
8. NCNO
9. BOX
10. CRM

Go back to Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine
Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.21 -0.23 (2.44%)
Previous Close $9.44    52 Week High $9.23 
Open $9.33    52 Week Low $1.16 
Day High $9.44    P/E N/A 
Day Low $9.13    EPS $-0.30 
Volume 3,508,445